Mary M McDermott1, Lu Tian2, Michael H Criqui3, Luigi Ferrucci4, Michael S Conte5, Lihui Zhao6, Lingyu Li7, Robert Sufit8, Tamar S Polonsky9, Melina R Kibbe10, Philip Greenland6, Christiaan Leeuwenburgh11, Jack M Guralnik12. 1. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill. Electronic address: mdm608@northwestern.edu. 2. Department of Biomedical Science Data, Stanford Medicine, Stanford University, Stanford, Calif. 3. Department of Family Medicine and Public Health, University of California at San Diego, La Jolla, Calif. 4. Division of Intramural Research, National Institute on Aging, National Institutes of Health, Bethesda, Md. 5. Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, Calif. 6. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill. 7. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill. 8. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Ill. 9. Department of Medicine, University of Chicago, Chicago, Ill. 10. Division of Vascular and Endovascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. 11. Department of Aging and Geriatric Research, University of Florida, Gainesville, Fla. 12. Department of Epidemiology, University of Maryland, College Park, Md.
Abstract
OBJECTIVE: The 6-minute walk test is a common outcome measure in clinical trials of people with lower extremity peripheral artery disease (PAD). However, what constitutes a meaningful change in the 6-minute walk distance has not been well defined for people with PAD. The present study related the change in the 6-minute walk distance to the degree of participant-reported improvement or decline in the 6-minute walk distance to define a meaningful change in the 6-minute walk distance for those with PAD. METHODS: Participants with PAD from three observational longitudinal studies completed the walking impairment questionnaire (WIQ) distance score and 6-minute walk at baseline and 1 year later. The WIQ distance score measures participants' perceived difficulty walking seven different distances without stopping (ranging from walking around the home to walking 5 blocks) on a 0 to 4 Likert scale, with 0 representing an inability to walk the distance and 4 representing no difficulty. The mean changes in the 6-minute walk distance corresponding to the participants' report of no change, 1-unit change, or 2-unit change, respectively, in the Likert scale score between the baseline and 1-year follow-up measures were calculated for each WIQ distance. RESULTS: A total of 777 participants with PAD (mean age, 71.2 ± 8.8 years; mean baseline 6-minute walk distance, 350.1 ± 118.1 meters) completed 5439 questions about their difficulty walking each WIQ distance at baseline and follow-up. Participants with PAD who reported no change in their difficulty in walking each WIQ distance between baseline and follow-up had a decline of 7.2 meters (95% confidence interval [CI], -11.6 to -2.8 meters) in the 6-minute walk test. Relative to those reporting no change in difficulty walking, the participants reporting 1- and 2-point improvements in walking ability showed 6-minute walk distance improvements of 7.8 meters (95% CI, -0.3 to 15.9 meters) and 20.1 meters (95% CI, 1.1-39.2 meters), respectively. Relative to those reporting no change in walking difficulty, those reporting 1- and 2-point declines in perceived walking difficulty showed declines of -11.2 meters (95% CI, -19.0 to -3.4 meters) and -23.8 meters (95% CI, -37.4 to -10.3 meters) in the 6-minute walk distance. CONCLUSIONS: Among people with PAD, ∼8- and ∼20-meter improvements in the 6-minute walk distance represent small and large improvements in walking ability, respectively. People with PAD who reported no change in their ability to walk distances over 1 year simultaneously declined by a mean of 7 meters in the 6-minute walk test. These findings will be useful for interpreting the results from randomized trials of interventions to improve the walking performance of people with PAD.
OBJECTIVE: The 6-minute walk test is a common outcome measure in clinical trials of people with lower extremity peripheral artery disease (PAD). However, what constitutes a meaningful change in the 6-minute walk distance has not been well defined for people with PAD. The present study related the change in the 6-minute walk distance to the degree of participant-reported improvement or decline in the 6-minute walk distance to define a meaningful change in the 6-minute walk distance for those with PAD. METHODS: Participants with PAD from three observational longitudinal studies completed the walking impairment questionnaire (WIQ) distance score and 6-minute walk at baseline and 1 year later. The WIQ distance score measures participants' perceived difficulty walking seven different distances without stopping (ranging from walking around the home to walking 5 blocks) on a 0 to 4 Likert scale, with 0 representing an inability to walk the distance and 4 representing no difficulty. The mean changes in the 6-minute walk distance corresponding to the participants' report of no change, 1-unit change, or 2-unit change, respectively, in the Likert scale score between the baseline and 1-year follow-up measures were calculated for each WIQ distance. RESULTS: A total of 777 participants with PAD (mean age, 71.2 ± 8.8 years; mean baseline 6-minute walk distance, 350.1 ± 118.1 meters) completed 5439 questions about their difficulty walking each WIQ distance at baseline and follow-up. Participants with PAD who reported no change in their difficulty in walking each WIQ distance between baseline and follow-up had a decline of 7.2 meters (95% confidence interval [CI], -11.6 to -2.8 meters) in the 6-minute walk test. Relative to those reporting no change in difficulty walking, the participants reporting 1- and 2-point improvements in walking ability showed 6-minute walk distance improvements of 7.8 meters (95% CI, -0.3 to 15.9 meters) and 20.1 meters (95% CI, 1.1-39.2 meters), respectively. Relative to those reporting no change in walking difficulty, those reporting 1- and 2-point declines in perceived walking difficulty showed declines of -11.2 meters (95% CI, -19.0 to -3.4 meters) and -23.8 meters (95% CI, -37.4 to -10.3 meters) in the 6-minute walk distance. CONCLUSIONS: Among people with PAD, ∼8- and ∼20-meter improvements in the 6-minute walk distance represent small and large improvements in walking ability, respectively. People with PAD who reported no change in their ability to walk distances over 1 year simultaneously declined by a mean of 7 meters in the 6-minute walk test. These findings will be useful for interpreting the results from randomized trials of interventions to improve the walking performance of people with PAD.
Authors: Mary M McDermott; Jack M Guralnik; Lu Tian; Lihui Zhao; Tamar S Polonsky; Melina R Kibbe; Michael H Criqui; Dongxue Zhang; Michael S Conte; Kathryn Domanchuk; Lingyu Li; Robert Sufit; Christiaan Leeuwenburgh; Luigi Ferrucci Journal: J Vasc Surg Date: 2019-12-23 Impact factor: 4.268
Authors: Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci Journal: Circulation Date: 2014-07-01 Impact factor: 29.690
Authors: Michael S Conte; Frank B Pomposelli; Daniel G Clair; Patrick J Geraghty; James F McKinsey; Joseph L Mills; Gregory L Moneta; M Hassan Murad; Richard J Powell; Amy B Reed; Andres Schanzer; Anton N Sidawy Journal: J Vasc Surg Date: 2015-01-28 Impact factor: 4.268
Authors: A W Gardner; L I Katzel; J D Sorkin; D D Bradham; M C Hochberg; W R Flinn; A P Goldberg Journal: J Am Geriatr Soc Date: 2001-06 Impact factor: 5.562
Authors: M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin Journal: JAMA Date: 2001-10-03 Impact factor: 56.272
Authors: Mary M McDermott; Philip Ades; Jack M Guralnik; Alan Dyer; Luigi Ferrucci; Kiang Liu; Miriam Nelson; Donald Lloyd-Jones; Linda Van Horn; Daniel Garside; Melina Kibbe; Kathryn Domanchuk; James H Stein; Yihua Liao; Huimin Tao; David Green; William H Pearce; Joseph R Schneider; David McPherson; Susan T Laing; Walter J McCarthy; Adhir Shroff; Michael H Criqui Journal: JAMA Date: 2009-01-14 Impact factor: 56.272
Authors: Mary M McDermott; Bonnie Spring; Jeffrey S Berger; Diane Treat-Jacobson; Michael S Conte; Mark A Creager; Michael H Criqui; Luigi Ferrucci; Heather L Gornik; Jack M Guralnik; Elizabeth A Hahn; Peter Henke; Melina R Kibbe; Debra Kohlman-Trighoff; Lingyu Li; Donald Lloyd-Jones; Walter McCarthy; Tamar S Polonsky; Christopher Skelly; Lu Tian; Lihui Zhao; Dongxue Zhang; W Jack Rejeski Journal: JAMA Date: 2018-04-24 Impact factor: 56.272
Authors: Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh Journal: Circulation Date: 2016-11-13 Impact factor: 29.690
Authors: Jacob C Monroe; Byung Joon Pae; Christopher Kargl; Timothy P Gavin; Jason Parker; Susan M Perkins; Yan Han; Janet Klein; Raghu L Motaganahalli; Bruno T Roseguini Journal: J Appl Physiol (1985) Date: 2022-06-30
Authors: Mary M McDermott; Lydia Bazzano; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Kathryn Domanchuk; Lihui Zhao; Tamar S Polonsky; Dongxue Zhang; Donald Lloyd-Jones; Christiaan Leeuwenburgh; Jack M Guralnik; Melina R Kibbe; Kate Kosmac; Michael H Criqui; Lu Tian Journal: JAMA Date: 2022-10-04 Impact factor: 157.335
Authors: Mary M McDermott; Bonnie Spring; Lu Tian; Diane Treat-Jacobson; Luigi Ferrucci; Donald Lloyd-Jones; Lihui Zhao; Tamar Polonsky; Melina R Kibbe; Lydia Bazzano; Jack M Guralnik; Daniel E Forman; Al Rego; Dongxue Zhang; Kathryn Domanchuk; Christiaan Leeuwenburgh; Robert Sufit; Brittany Smith; Todd Manini; Michael H Criqui; W Jack Rejeski Journal: JAMA Date: 2021-04-06 Impact factor: 56.272
Authors: Ahmed Ismaeel; K Leigh Greathouse; Nathan Newton; Dimitrios Miserlis; Evlampia Papoutsi; Robert S Smith; Jack L Eidson; David L Dawson; Craig W Milner; Robert J Widmer; William T Bohannon; Panagiotis Koutakis Journal: Nutrients Date: 2021-06-22 Impact factor: 5.717
Authors: Mary M McDermott; Luigi Ferrucci; Marta Gonzalez-Freire; Kate Kosmac; Christiaan Leeuwenburgh; Charlotte A Peterson; Sunil Saini; Robert Sufit Journal: Arterioscler Thromb Vasc Biol Date: 2020-09-17 Impact factor: 10.514
Authors: Nicola Lamberti; Giovanni Piva; Federico Businaro; Lorenzo Caruso; Anna Crepaldi; Pablo Jesùs Lòpez-Soto; Fabio Manfredini Journal: J Pers Med Date: 2022-03-04